A detailed history of Washington Trust CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Washington Trust CO holds 76,927 shares of BDX stock, worth $18.6 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
76,927
Previous 78,529 2.04%
Holding current value
$18.6 Million
Previous $19.4 Million 7.48%
% of portfolio
0.66%
Previous 0.72%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 15, 2024

SELL
$225.07 - $246.17 $360,562 - $394,364
-1,602 Reduced 2.04%
76,927 $18 Million
Q1 2024

Apr 23, 2024

SELL
$233.45 - $247.73 $8,170 - $8,670
-35 Reduced 0.04%
78,529 $19.4 Million
Q4 2023

Jan 18, 2024

SELL
$232.24 - $267.23 $322,813 - $371,449
-1,390 Reduced 1.74%
78,564 $19.2 Million
Q3 2023

Oct 18, 2023

SELL
$254.9 - $283.59 $264,841 - $294,650
-1,039 Reduced 1.28%
79,954 $20.7 Million
Q2 2023

Jul 27, 2023

SELL
$238.39 - $265.32 $236,959 - $263,728
-994 Reduced 1.21%
80,993 $21.4 Million
Q1 2023

May 10, 2023

BUY
$229.71 - $259.35 $18.7 Million - $21.1 Million
81,435 Added 100537.04%
81,516 $20.2 Million
Q1 2023

May 04, 2023

SELL
$229.71 - $259.35 $18.8 Million - $21.2 Million
-81,871 Reduced 99.9%
81 $20.2 Million
Q4 2022

Jul 27, 2023

BUY
$218.29 - $256.91 $102,814 - $121,004
471 Added 0.58%
81,987 $20.9 Million
Q4 2022

Feb 08, 2023

SELL
$218.29 - $256.91 $896,298 - $1.05 Million
-4,106 Reduced 4.77%
81,952 $20.8 Million
Q3 2022

Oct 14, 2022

SELL
$51.03 - $264.23 $37,915 - $196,322
-743 Reduced 0.86%
86,058 $19.2 Million
Q2 2022

Jul 25, 2022

BUY
$234.74 - $275.42 $66,666 - $78,219
284 Added 0.33%
86,801 $21.4 Million
Q1 2022

May 05, 2022

BUY
$243.64 - $270.48 $836,659 - $928,828
3,434 Added 4.13%
86,517 $23 Million
Q4 2021

Feb 09, 2022

SELL
$230.08 - $250.94 $22 Million - $24 Million
-95,717 Reduced 53.53%
83,083 $20.9 Million
Q3 2021

Nov 09, 2021

BUY
$232.72 - $256.47 $90,062 - $99,253
387 Added 0.22%
178,800 $44 Million
Q2 2021

Aug 05, 2021

SELL
$232.65 - $254.58 $160,761 - $175,914
-691 Reduced 0.39%
178,413 $43.4 Million
Q1 2021

Apr 28, 2021

SELL
$232.09 - $256.88 $61,039 - $67,559
-263 Reduced 0.15%
179,104 $43.6 Million
Q4 2020

Feb 09, 2021

BUY
$221.92 - $245.94 $114,732 - $127,150
517 Added 0.29%
179,367 $44.9 Million
Q3 2020

Nov 05, 2020

BUY
$215.77 - $276.76 $20 Million - $25.7 Million
92,917 Added 108.13%
178,850 $41.6 Million
Q2 2020

Aug 04, 2020

SELL
$219.9 - $263.41 $21.2 Million - $25.4 Million
-96,537 Reduced 52.91%
85,933 $20 Million
Q1 2020

May 07, 2020

BUY
$195.69 - $279.01 $18.4 Million - $26.2 Million
93,912 Added 106.05%
182,470 $41.9 Million
Q4 2019

Feb 12, 2020

BUY
$236.45 - $266.82 $238,814 - $269,488
1,010 Added 1.15%
88,558 $24.1 Million
Q3 2019

Nov 06, 2019

SELL
$230.58 - $256.08 $39,890 - $44,301
-173 Reduced 0.2%
87,548 $22.4 Million
Q2 2019

Aug 07, 2019

BUY
$217.4 - $246.08 $193,051 - $218,519
888 Added 1.02%
87,721 $22.1 Million
Q1 2019

May 13, 2019

SELL
$206.05 - $248.17 $295,887 - $356,372
-1,436 Reduced 1.63%
86,833 $20.2 Million
Q4 2018

Feb 11, 2019

SELL
$204.73 - $257.93 $203,296 - $256,124
-993 Reduced 1.11%
88,269 $19.9 Million
Q3 2018

Nov 13, 2018

SELL
$233.07 - $256.0 $429,081 - $471,296
-1,841 Reduced 2.02%
89,262 $23.3 Million
Q2 2018

Aug 10, 2018

SELL
$208.1 - $233.85 $27,469 - $30,868
-132 Reduced 0.14%
91,103 $21.8 Million
Q1 2018

May 10, 2018

SELL
$205.46 - $240.27 $784,651 - $917,591
-3,819 Reduced 4.02%
91,235 $19.8 Million
Q4 2017

Feb 05, 2018

BUY
$189.0 - $222.64 $389,718 - $459,083
2,062 Added 2.22%
95,054 $20.3 Million
Q3 2017

Oct 31, 2017

BUY
$186.89 - $198.9 $17.4 Million - $18.5 Million
92,992
92,992 $18.2 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $68.9B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Washington Trust CO Portfolio

Follow Washington Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust CO with notifications on news.